XOMA Congratulates Rezolute on Its Successful Financing and Progress Towards Initiating Phase 2b Study for RZ358

Aug 01, 2019

We are excited to share the news that one of our partners, Rezolute, Inc., announced it intends to commence Phase 2b study for RZ358 later this year, in conjunction with its recent completion of a $45 million investment round. XOMA received a $2.9 million milestone payment related to the completed financing. In addition to RZ358, XOMA holds a royalty interest in three additional Rezolute assets. To see the full story, click here: